CTRI/2021/04/032694尚未招募4 期
Supplemental Nicotinamide In the Treatment of Schizophrenia (SNITS): A clinical trial to reduce severity of symptoms of schizophrenia - SNITS
Schizophrenia Research Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •(1) a diagnosis of SZ or schizoaffective disorder
- •(2) no change in their anti-psychotic medication over the last 4 weeks
- •(3) have the capacity to consent to the study and comply with study procedures.
排除标准
- •(1) having a known or suspected active systemic medical disorder
- •(2) currently pregnant or breastfeeding
- •(3) currently enrolled in any other medical trial
- •(4) currently taking any niacin supplement or daily multivitamin.
研究者
相似试验
进行中（未招募）
1 期
Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat levelDialysis-dependent patients with hyperphosphatemiaMedDRA version: 17.0Level: LLTClassification code 10020712Term: HyperphosphatemiaSystem Organ Class: 100000004861EUCTR2013-000488-95-PLMEDICE Arzneimittel Pütter GmbH & Co. KG700
进行中（未招募）
1 期
Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat levelDialysis-dependent patients with hyperphosphatemiaMedDRA version: 19.0Level: LLTClassification code 10020712Term: HyperphosphatemiaSystem Organ Class: 100000004861EUCTR2013-000488-95-ATMEDICE Arzneimittel Pütter GmbH & Co. KG700
进行中（未招募）
不适用
Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat levelEUCTR2013-000488-95-HUMEDICE Arzneimittel Pütter GmbH & Co. KG700
进行中（未招募）
1 期
Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat levelDialysis-dependent patients with hyperphosphatemiaMedDRA version: 19.0Level: LLTClassification code 10020712Term: HyperphosphatemiaSystem Organ Class: 100000004861EUCTR2013-000488-95-DEMEDICE Arzneimittel Pütter GmbH & Co. KG700
已完成
4 期
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical neuroleptics: A double-blind, randomised, placebo controlled trialMental Health - SchizophreniaSchizophreniaACTRN12605000577617niversity of Melbourne40